Array Biopharma (ARRY) Tops Q3 EPS by 38c
Tweet
Share
E-mailGet Alerts ARRY Hot Sheet
Price: $7.02 +0.72%
EPS Growth %: -52.0%
Financial Fact:
Interest expense: -2.98M
Today's EPS Names:
CRMT, PKE, More
EPS Growth %: -52.0%
Financial Fact:
Interest expense: -2.98M
Today's EPS Names:
CRMT, PKE, More
Join SI Premium – FREE
Array Biopharma (NASDAQ: ARRY) reported Q3 EPS of $0.37, $0.38 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $6.6 million versus the consensus estimate of $6 million.
For earnings history and earnings-related data on Array Biopharma (ARRY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- Morgan Stanley Resumes Kohl's (KSS) at Underweight
- Tepper’s Appaloosa soars 32% in H1 on prescient memory-chip bets - report
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
